ASH Annual Meeting and Exposition
ASH Annual Meeting and Exposition
January 13, 2016
2 min watch
Save

VIDEO: Eltrombopag increases hematologic response in severe aplastic anemia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO, Fla. — Mrinal S. Patnaik, MBBS, offers perspective on a late-breaking abstract from the ASH Annual Meeting and Exposition that showed the addition of eltrombopag to immunosuppressive treatment with horse antithymocyte globulin and cyclosporine increased response rates in patients with treatment-naive severe aplastic anemia.